CYTOMEGALOVIRUS PNEUMONITIS AFTER ALLOGENEIC MARROW TRANSPLANTATION

被引：0
作者：
BRENNER, MK
GRIFFITHS, PD
PRENTICE, HG
机构：
[1] ROYAL FREE HOSP,DEPT VIROL,LONDON NW3 2QG,ENGLAND
[2] ROYAL FREE HOSP,BONE MARROW TRANSPLANTAT PROGRAMME,LONDON NW3 2QG,ENGLAND
来源：
LANCET | 1987年 / 2卷 / 8553期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：286 / 287
页数：2
相关论文
共 50 条
  • [21] DIAGNOSTIC YIELD OF BRONCHOALVEOLAR LAVAGE IN PNEUMONITIS OCCURRING AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    CORDONNIER, C
    BERNAUDIN, JF
    FLEURY, J
    FEUILHADE, M
    HAIOUN, C
    PAYEN, D
    HUET, Y
    ATASSI, K
    VERNANT, JP
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1985, 132 (05): : 1118 - 1123
  • [22] DIRECTED GANCICLOVIR (DHPG) PROPHYLAXIS AGAINST CYTOMEGALOVIRUS (CMV) PNEUMONITIS IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    SCHROEDER, M
    ESSELL, J
    HARMAN, G
    HALVORSON, R
    DOLAN, M
    CALLANDER, N
    SNYDER, M
    WILKS, S
    ALLERTON, J
    THOMPSON, J
    [J]. BLOOD, 1993, 82 (10) : A425 - A425
  • [23] PROPHYLAXIS OF CYTOMEGALOVIRUS DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
    GRIGG, A
    PHILLIPS, G
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (05) : 972 - 972
  • [24] PROPHYLAXIS OF CYTOMEGALOVIRUS-INFECTION WITH GANCICLOVIR IN ALLOGENEIC MARROW TRANSPLANTATION
    YAU, JC
    DIMOPOULOS, MA
    HUAN, SD
    TARRAND, JJ
    SPENCER, V
    SPITZER, G
    MENEGHETTI, CM
    WALLERSTEIN, RO
    ANDERSSON, BS
    LEMAISTRE, CF
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1991, 47 (05) : 371 - 376
  • [25] CYTOMEGALOVIRUS INTERSTITIAL PNEUMONITIS FOLLOWING ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
    许晓华
    黄连生
    张晓红
    朱康儿
    徐炀
    吴东
    赵小英
    [J]. ChineseJournalofCancerResearch, 2005, (04) : 294 - 297
  • [26] CYTOMEGALOVIRUS ANTIGEN-DETECTION IN PERIPHERAL-BLOOD LEUKOCYTES AFTER ALLOGENEIC MARROW TRANSPLANTATION
    BOECKH, M
    BOWDEN, RA
    GOODRICH, JM
    PETTINGER, M
    MEYERS, JD
    [J]. BLOOD, 1992, 80 (05) : 1358 - 1364
  • [27] Oral versus intravenous ganciclovir for the prophylaxis of cytomegalovirus disease after allogeneic bone marrow transplantation
    Szer, J
    Durrant, S
    Schwarer, AP
    Bradstock, KF
    Gibson, J
    Arthur, C
    To, LB
    Hughes, T
    Raunow, H
    [J]. INTERNAL MEDICINE JOURNAL, 2004, 34 (03) : 98 - 101
  • [28] EARLY TREATMENT WITH GANCICLOVIR TO PREVENT CYTOMEGALOVIRUS DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    GOODRICH, JM
    MORI, M
    GLEAVES, CA
    DUMOND, C
    CAYS, M
    EBELING, DF
    BUHLES, WC
    DEARMOND, B
    MEYERS, JD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (23) : 1601 - 1607
  • [29] ABORTIVE HUMAN CYTOMEGALOVIRUS-INFECTION IN PATIENTS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    DEGAST, GC
    BOLAND, GJ
    VLIEGER, AM
    DEWEGER, RA
    VERDONCK, LF
    ZWAAN, FE
    JIWA, NM
    [J]. BONE MARROW TRANSPLANTATION, 1992, 9 (04) : 221 - 225
  • [30] Prevention of Cytomegalovirus Infection by Valaciclovir after Allogeneic Bone Marrow Transplantation from an Unrelated Donor
    Takehiko Mori
    Yoshinobu Aisa
    Takayuki Shimizu
    Tomonori Nakazato
    Rie Yamazaki
    Yasuo Ikeda
    Shinichiro Okamoto
    [J]. International Journal of Hematology, 2006, 83 : 266 - 270
12345